<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Context:Stress is suggested to lead to metabolic dysregulations as clustered in the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Although dysregulation of the autonomic <z:mp ids='MP_0008912'>nervous</z:mp> system is found to associate with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and its dysregulations, no longitudinal study has been performed to date to examine the predictive value of this stress-system in the development of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>.Objective:We examined whether autonomic <z:mp ids='MP_0008912'>nervous</z:mp> system functioning predicts 2-year development of <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> that constitute the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>.Design:Baseline and 2-year follow-up of a prospective cohort: the Netherlands Study of <z:hpo ids='HP_0000716'>Depression</z:hpo> and <z:hpo ids='HP_0000739'>Anxiety</z:hpo> (NESDA).Setting:General community, primary care, and specialized mental health care.Participants:1933 participants aged 18-65 years.Main outcome measures:ANS measures included heart rate (HR), respiratory sinus <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> (RSA, high RSA reflecting high parasympathetic activity), pre-ejection period (PEP, high PEP reflecting low sympathetic activity), cardiac autonomic balance (CAB) and cardiac autonomic regulation (CAR) </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> was based on the updated Adult Treatment Panel III criteria and included high waist circumference, serum <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, blood pressure, serum <z:chebi fb="105" ids="17234">glucose</z:chebi>, and low <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol.Results:Baseline short PEP, low CAB, and high HR and CAR were predictors of increase in number of components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> during follow-up </plain></SENT>
<SENT sid="3" pm="."><plain>High HR and low CAB were predictors of 2-year decrease in <z:chebi fb="6" ids="39025">high-density-lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol, and 2-year increase in diastolic and systolic blood pressure </plain></SENT>
<SENT sid="4" pm="."><plain>Short PEP and high CAR also predicted 2-year increase in systolic blood pressure, and short PEP additionally predicted 2-year increase in diastolic blood pressure </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, a low baseline RSA was predictive for subsequent decrease in <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>.Conclusion:Increased sympathetic activity predicts an increase in <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> over time </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that a dysregulation of the autonomic <z:mp ids='MP_0008912'>nervous</z:mp> system is an important predictor of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> through dysregulating <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism and blood pressure over time </plain></SENT>
</text></document>